Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Stuttgart - Delayed Quote • EUR Jazz Pharmaceuticals PLC (J7Z.SG) Follow Add holdings 90.50 -1.08 (-1.18%) As of 8:00:52 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for J7Z.SG 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: J7Z.SG View More All News Press Releases SEC Filings Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 Jazz Pharmaceuticals Completes Acquisition of Chimerix After a year of 4.3% returns, Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) share price drop last week may have less of an impact on institutional investors Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference TPB, ACB and JAZZ: Three Pot Stocks Flowering With Potential Upside Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio Statutory Profit Doesn't Reflect How Good Jazz Pharmaceuticals' (NASDAQ:JAZZ) Earnings Are Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year